Drug Type Small molecule drug |
Synonyms PHI 201, PHI-201 |
Target |
Mechanism KRAS gene inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of Lung | Preclinical | KR | 30 Jan 2022 | |
Pancreatic Cancer | Preclinical | KR | 30 Jan 2022 | |
Colorectal Cancer | Preclinical | KR | - |